Close Menu

This week in the Proceedings of the National Academy of Sciences, scientists at the Ludwig Institute for Cancer Research in Sao Paulo have used bioinformatics to build the human cell surfaceome. From this catalog of 3,702 cell surface transmembrane proteins, they were able to look at gene expression differences to find surfaceome genes that could be possible tumor targets, 593 of which they validated using qPCR.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.